Hepatic graft-versus-host disease resembling acute hepatitis: Additional treatment with ursodeoxycholic acid

Liver

Volumn 22, Issue 6, 2002, Pages 514-517

  Chiba, Tetsuhiro ^a   Yokosuka, Osamu ^a   Kanda, Tatsuo ^a   Fukai, Kenichi ^a   Imazeki, Fumio ^a   Saisho, Hiromitsu ^a   Nishimura, M ^a   Saito, Yasushi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Acute hepatitis; BMT; Cholestasis; GVHD; UDCA

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEPARIN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; LEVOFLOXACIN; METHOTREXATE; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT DISEASE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHRONIC HEPATITIS; DRUG EFFECT; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER GRAFT; MALE; THROMBOSIS;

ACUTE DISEASE; ADULT; BILE DUCT DISEASES; BONE MARROW TRANSPLANTATION; CHOLAGOGUES AND CHOLERETICS; CYCLOSPORINE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; GRAFT VS HOST DISEASE; HEPATITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; MALE; PREDNISOLONE; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0036901798     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2002.01734.x     Document Type: Article

References (18)

1. POUPON R E, BALKAU B, ESCHWEGE E, et al. Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-54.
2. BEUERS U, SPENGLER U, KRUIS W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992; 16: 707-14.
3. OHASHI K, TANABE J, WATANABE R, et al. The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. Am J Hematol 2000; 64: 32-8.
4. BARNES D, TALENTI D, CAMMELL G, et al. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection. Hepatology 1997; 26: 853-7.
5. SNOVER D C. Acute and chronic graft versus host disease. Human Pathol 1984; 15: 202-5.
6. HOOD A F, VOGELSUNG G B, BLACK C, FARMER E R, SNATOS G W. Acute graft versus host disease: development following autologous and syngeneic bone marrow transplantation. Ann Intern Med 1981; 94: 210.
7. VOGELSANG G B, HESS A D. Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-7.
8. SHULMAN H M, SULLIVAN K M, WEIDEN P L, et al. Chronic graft versus host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-47.
9. STECHSCHULTE D J JR, FISHBACK J L, EMAMI A, BHATIA P. Secondary biliary cirrhosis as a consequence of graft-versus-host disease. Gastroenterol 1990; 98: 223-5.
10. MALIK A H, COLLINS R H JR, SABOORIAN M H, LEE W M. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis. Am J Gastroenterol 2001; 96: 588-90.
11. FUJII N, TAKENAKA K, SHINAGAWA K, et al. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 27: 1007-10.
12. STRASSER S I, SHULUMAN H M, FLOWERS M E, et al. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000; 32: 1265-71.
13. LAZARIDIS K N, GORES G J, LINDOR K D. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol 2001; 35: 134-46.
14. HILL G R, FERRARA J L M. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rational for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-9.
15. FRIED R H, MURAKAMI C S, FISHER L D, et al. Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. Ann Intern Med 1992; 16: 624-9.
16. WULFFRAAT N M, HADDAD E, BENKERROU M, et al. Hepatoc GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid. Br J Haematol 1997; 96: 776-80.
17. CALMUS Y, GANE P, ROUGER P, POUPON R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1989; 11: 12-5.
18. YOSHIKAWA M, TSUJI T, MATSUMURA K, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1991; 16: 358-64.